Biontech sec filings Indeed lately is being hunted by users around us, perhaps one of you personally. Individuals are now accustomed to using the internet in gadgets to see video and image data for inspiration, and according to the title of this post I will talk about about Biontech Sec Filings.
Find, Read, And Discover Biontech Sec Filings, Such Us:
If you re searching for Albert Bourla you've arrived at the ideal location. We ve got 100 images about albert bourla adding images, photos, photographs, wallpapers, and much more. In these webpage, we also provide variety of graphics out there. Such as png, jpg, animated gifs, pic art, logo, black and white, transparent, etc.
Albert bourla. Securities and exchange commission. As filed with the securities and exchange commission on october 9 2019. Sec filings group any 345 annual filings current reports mergers acquisitions other proxy filings quarterly filings registration statements filing year any 2020 2019.
Infoatbiontechde we aspire to individualize cancer medicine. The securities act of 1933. Biontech se is primarely in the business of biological products no diagnostic substances.
Biontech se translation of registrants name into english an der goldgrube 12 d 55131. Biontech is a germany based biotechnology company that focuses on developing cancer therapeutics including individualized immunotherapy as well as vaccines for infectious. Rights offering for up to 7505596 ordinary shares including ordinary shares represented by american depositary shares.
For a discussion of these and other risks and uncertainties see biontechs annual report on form 20 f filed with the sec on march 31 2020 which has been filed with the sec and is available on the secs website at wwwsecgov. Bion environmental technologies inc. Sec filings for bion environmental technologies.
For the month of october 2020. An der goldgrube 12 55131 mainz germany t. Biontech se exact name of registrant as specified in its charter not.
This page includes all sec registration details as well as a list of all documents s 1 prospectus current reports 8 k 10k annual reports filed by biontech se. 49 6131 9084 0 f. All information in this press release is as of the date of the release and biontech undertakes no duty to update.
Report of foreign private issuer pursuant to rule 13a16 or 15d16 under the securities exchange act of 1934. 49 6131 9084 390 m. Together with all of the other information contained in the prospectus and in our filings with the securities and exchange commission that we have incorporated by reference in the prospectus.
This page includes all sec registration details as well as a list of all documents s 1 prospectus current reports 8 k 10k annual reports filed by biontech se.
Incoming Search Terms: